Streetbeat News

Price Targets

SO

Morgan Stanley analyst Stephen Byrd has maintained an Equal-Weight rating on Southern Company (NYSE:SO) and increased the price target from $66 to $67.

Portfolio Pulse from Benzinga Newsdesk

November 21, 2023 | 3:25 pm

SHCO

Morgan Stanley has maintained an Equal-Weight rating on Soho House (NYSE:SHCO) and increased the price target from $6.5 to $7.

Portfolio Pulse from Benzinga Newsdesk

November 21, 2023 | 3:23 pm

MOH

Cantor Fitzgerald analyst Sarah James has reiterated an Overweight rating on Molina Healthcare (NYSE:MOH) and maintained a price target of $374.

Portfolio Pulse from Benzinga Newsdesk

November 21, 2023 | 3:21 pm

HUM

Cantor Fitzgerald analyst Sarah James has reiterated an Overweight rating on Humana (NYSE:HUM) and maintained a price target of $597.

Portfolio Pulse from Benzinga Newsdesk

November 21, 2023 | 3:19 pm

ELV

Cantor Fitzgerald analyst Sarah James has reiterated an Overweight rating on Elevance Health (NYSE:ELV) and maintained a price target of $547.

Portfolio Pulse from Benzinga Newsdesk

November 21, 2023 | 3:17 pm

CVS

Cantor Fitzgerald analyst Sarah James has reiterated an Overweight rating on CVS Health (NYSE:CVS) with a maintained price target of $87.

Portfolio Pulse from Benzinga Newsdesk

November 21, 2023 | 3:11 pm

CNC

Cantor Fitzgerald analyst Sarah James has reiterated an Overweight rating on Centene Corporation (NYSE:CNC) and maintained a price target of $82.

Portfolio Pulse from Benzinga Newsdesk

November 21, 2023 | 3:09 pm

RCEL

Cantor Fitzgerald analyst Ross Osborn has reiterated an Overweight rating on AVITA Medical (NASDAQ:RCEL) and maintained a $20 price target on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

November 21, 2023 | 3:02 pm

WEC

WEC Energy Group (NYSE:WEC) received mixed analyst ratings in the last quarter with 1 bullish, 1 somewhat bullish, 4 indifferent, and 1 somewhat bearish rating. The average 12-month price target among 7 analysts is $87.0, with a high of $95.00 and a low of $80.00. This target is a 7.84% decrease from the previous average of $94.40. Analyst ratings are opinions on stock performance based on research and are updated typically once a quarter.

Portfolio Pulse from Benzinga Insights

November 21, 2023 | 3:00 pm

EXC

Exelon (NASDAQ:EXC) has received 6 analyst ratings in the last quarter, with 4 somewhat bullish, 2 indifferent, and none bearish. The average 12-month price target for Exelon is $42.67, with a high of $45.00 and a low of $40.00. This target has decreased by 3.46% from the previous target of $44.20. Analysts rate stocks typically once a quarter and provide insights on earnings, revenue, and growth estimates.

Portfolio Pulse from Benzinga Insights

November 21, 2023 | 3:00 pm